WHO monographs on selected medicinal plants - travolekar.ru
WHO monographs on selected medicinal plants - travolekar.ru
WHO monographs on selected medicinal plants - travolekar.ru
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
F<strong>ru</strong>ctus Macrocarp<strong>on</strong>ii<br />
Medicinal uses<br />
Uses supported by clinical data<br />
Orally as adjunct therapy for the preventi<strong>on</strong> and symptomatic treatment<br />
of urinary tract infecti<strong>on</strong>s in adults (8–20). Two clinical trials have assessed<br />
the effect of the f<strong>ru</strong>it juice in paediatric populati<strong>on</strong>s (17, 21), but<br />
the results were negative. Results from clinical trials involving the use of<br />
cranberry for the treatment of children with neurogenic bladder were also<br />
negative and do not support the use of cranberry products in paediatric<br />
populati<strong>on</strong>s (22).<br />
Uses described in pharmacopoeias and well established documents<br />
No informati<strong>on</strong> was found.<br />
Uses described in traditi<strong>on</strong>al medicine<br />
Treatment of asthma, fever, loss of appetite, scurvy and stomach ailments,<br />
as well as gallbladder and liver disease and for treatment of wounds (3, 23).<br />
Pharmacology<br />
Experimental pharmacology<br />
Antimicrobial and antiadhesive activity<br />
A c<strong>on</strong>centrated extract of the juice of the c<strong>ru</strong>de d<strong>ru</strong>g was tested for activity<br />
against the following pathogens: Alcaligenes faecalis, Clostridium perfringens,<br />
Enterococcus faecalis, Escherichia coli, Mycobacterium phlei,<br />
Pseudom<strong>on</strong>as ae<strong>ru</strong>ginosa, Salm<strong>on</strong>ella california, Salm<strong>on</strong>ella enteritidis,<br />
Salm<strong>on</strong>ella typhimurium, Shigella s<strong>on</strong>nei, Staphylococcus aureus and methicillin-resistant<br />
S. aureus, as well as Candida albicans. The c<strong>ru</strong>de d<strong>ru</strong>g<br />
c<strong>on</strong>centrate did not inhibit the growth of C. albicans, but had variable<br />
activity against the bacteria at diluti<strong>on</strong>s of 1:5 and 1:10 (24).<br />
Early investigati<strong>on</strong>s of the mechanism of cranberry’s bacteriostatic activity<br />
suggested that acidificati<strong>on</strong> of the urine may be resp<strong>on</strong>sible for its<br />
activity. However, more recent studies have dem<strong>on</strong>strated that urinary<br />
acidificati<strong>on</strong> is not the mechanism by which cranberry exerts its effects,<br />
but it does so through a mechanism that involves the inhibiti<strong>on</strong> of bacterial<br />
adherence (25–27). In vitro studies have shown that, in the 77 clinical<br />
isolates tested, cranberry juice decreased bacterial adherence of E. coli to<br />
uroepithelial cells by 60% when compared with saline soluti<strong>on</strong> (28). Furthermore,<br />
cranberry juice inhibited the adherence of E. coli to human urinary<br />
epithelial cells three times more st<strong>on</strong>gly than E. coli isolated from<br />
other clinical sources (27, 28). One study dem<strong>on</strong>strated that cranberry<br />
juice dose-dependently inhibited the haemagglutinati<strong>on</strong> activity of E. coli<br />
urinary isolates expressing type I and P adhesi<strong>on</strong> (27).<br />
153